| Line Item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||
| YoY growth | +360.4% | ||||||||
| Cost of revenues | |||||||||
| Gross profit (loss) | |||||||||
| % of revenue | 64.8% | ||||||||
| Operating expenses: | |||||||||
| Research and development | |||||||||
| General, administrative and marketing | |||||||||
| Total operating loss | |||||||||
| % of revenue | -484.3% | ||||||||
| Financial income (expenses), net | |||||||||
| Net loss for the period | |||||||||
| % of revenue | -484.6% | ||||||||
| Basic net loss per ordinary share (in Dollars per share) | |||||||||
| Diluted net loss per ordinary share (in Dollars per share) |